Menu

Investors

Tear Sheet

Tear Sheet

Corporate Profile

We are a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with chronic kidney disease.

Stock Chart

Minimum 15 minutes delayed. Source: LSEG

Stock Quote

Change
Volume
52 Week High
52 Week Low
Events
Date Details
August 5, 2026 at 4:30 PM EDT
Akebia’s Second Quarter 2026 Financial Results
Listen to webcast
June 4, 2026 at 7:35 AM EDT
2026 Jefferies Global Healthcare Conference
Listen to webcast
May 7, 2026 at 8:00 AM EDT
Akebia’s First Quarter 2026 Financial Results
Listen to webcast
News Releases

SEC Filings

Filing date Description View
Statement of changes in beneficial ownership of securities
0001591467-26-000004.pdf
Report of unscheduled material events or corporate event
0001517022-26-000050.pdf
Quarterly report which provides a continuing view of a company's financial position
0001517022-26-000051.pdf
Securities offered to employees pursuant to employee benefit plans
0001193125-26-335375.pdf
Statement of changes in beneficial ownership of securities
0001762507-26-000004.pdf
Print Page
Print Page
Email Page
Email Page
Contact IR
Contact IR
Email Alerts
Email Alerts
Tear Sheet
Tear Sheet

Akebia Therapeutics
180 Third Ave, Floor 2
Waltham, MA 02452

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us